Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 210.9 million | USD 331.7 million | 5.28% | 2023 |
The global Hemodialysis Vascular Grafts market size accrued earnings worth approximately USD 210.9 Million in 2023 and is predicted to gain revenue of about USD 331.7 Million by 2032, is set to record a CAGR of nearly 5.28% over the period from 2024 to 2032.
Hemodialysis vascular access dysfunctioning is a key reason for illness in the patients having hemodialysis and it also contributes notably towards total end-phase renal disorder expenses. This has resulted in huge demand for hemodialysis vascular grafts.
Moreover, rise in the occurrence of kidney ailments, acceptance of bio-engineered vascular grafts, and product innovations have raised the product penetration in healthcare sector globally in the recent years. Furthermore, less availability of kidney donors has resulted in patients opting for hemodialysis, thereby steering the demand for hemodialysis vascular grafts.
A prominent awareness about the advantages of using vascular grafts during hemodialysis procedures for patients with kidney disorders will drive the market growth over the estimated timeframe. In addition to this, patients prefer hemodialysis methods over kidney transplantations due to the huge costs and this will create huge demand for the cost-effective vascular grafts.
Apparently, these medical devices facilitate the proper blood flow, thereby ensuring accessibility of huge amount of blood required for performing hemodialysis. This will steer the business growth over the years ahead.
Moreover, due to complications involved due to use of synthetic arteriovenous access grafts during hemodialysis, the demand for biological vascular grafts is gaining traction in hemodialysis as it reduces probabilities of getting infection as well as low chances of rejection. This will create new growth avenues for the market over the years to come.
Apparently, improvement in healthcare infrastructure facilities witnessed in the emerging economies will unravel new horizons of growth for hemodialysis vascular grafts industry during the estimated timeline.
Report Attributes | Report Details |
---|---|
Report Name | Hemodialysis Vascular Grafts Market |
Market Size in 2023 | USD 210.9 Million |
Market Forecast in 2032 | USD 331.7 Million |
Growth Rate | CAGR of 5.28% |
Number of Pages | 110 |
Key Companies Covered | InnAVasc Medical Inc., C. R. Bard Inc., CryoLife Inc., W.L. Gore & Associates, LeMaitre Vascular Inc., Merit Medical Systems, Terumo Medical Corporation, Getinge AB, Vascular Genesis Inc., Proteon Therapeutics Inc., and others. |
Segments Covered | By Raw Material, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The growth of the industry in North America during the forecast timespan is owing to huge healthcare spending along with massive utilization of tissue engineered vascular grafts as well as biological vascular grafts during hemodialysis in countries like the U.S. and Canada. Apart from this, rise in the number of patients suffering from chronic renal ailments will enlarge the market scope in the region over the coming years.
Key players leveraging the market growth are
By Raw Material
By Region
FrequentlyAsked Questions
A prominent awareness about the advantages of using vascular grafts during hemodialysis procedures for patients with kidney disorders will drive the market growth over the estimated timeframe.
The global Hemodialysis Vascular Grafts market size accrued earnings worth approximately USD 210.9 Million in 2023 and is predicted to gain revenue of about USD 331.7 Million by 2032, is set to record a CAGR of nearly 5.28% over the period from 2024 to 2032.
North America will contribute remarkably towards the global market share over the estimated timeline.
The key market players include InnAVasc Medical, Inc., C. R. Bard, Inc., CryoLife, Inc., W.L. Gore & Associates, LeMaitre Vascular, Inc., Merit Medical Systems, Terumo Medical Corporation, Getinge AB, Vascular Genesis, Inc., and Proteon Therapeutics, Inc.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed